Labplus - innovative technology for medical diagnostics

“Labplus – innovative technology for medical diagnostics” is implemented under Sub-measure 1.1.1 Industrial research and development work implemented by enterprises of the Smart Growth Operational Programme 2014-2020. The main goal of the project is to develop a worldwide unique medical diagnostic technology that enables proposing a set of tests without the participation of a doctor and remotely suggesting the causes of pathology.
Project value
5 995 983,49 PLN
Contribution of European Funds
4 746 548,44 PLN

Labplus Healthcare

"Labplus Healthcare" co-financed by the European Union under the Smart Growth Operational Program 2014-2020, Measure 1.3: R&D activity financed with capital funds participation, Sub-measure 1.3.1: Support for R&D projects at the ‘pre-seed’ stage by proof of concept funds – BRIdge Alfa. The goal is to develop and implement a technological solution for medical platforms and medical portals that will enable automatic forecasting based on the results of laboratory tests and personalized medical interview.
Project value
1 100 000,00 PLN
Contribution of European Funds
880 000,00 PLN

Information on project funding

Promotional video

Video material realised with EU subsidies as part of the project implementation: "Labplus - a globally innovative medical diagnostics technology".